Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122249966 | 12224996 | 6 | F | 20151130 | 20160913 | 20160331 | 20160915 | EXP | DE-ROCHE-1671813 | ROCHE | 74.00 | YR | M | Y | 0.00000 | 20160915 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122249966 | 12224996 | 1 | PS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 99 | 125085 | 450 | MG | INFUSION | QOW | |||||
| 122249966 | 12224996 | 2 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 99 | 125085 | 425 | MG | QOW | ||||||
| 122249966 | 12224996 | 3 | SS | 5-FLUOROURACIL | FLUOROURACIL | 1 | Intravenous bolus | U | 99 | 0 | 650 | MG | QOW | ||||||
| 122249966 | 12224996 | 4 | SS | 5-FLUOROURACIL | FLUOROURACIL | 1 | Intravenous drip | U | 99 | 0 | 3400 | MG | QOW | ||||||
| 122249966 | 12224996 | 5 | SS | 5-FLUOROURACIL | FLUOROURACIL | 1 | Intravenous bolus | U | 99 | 0 | 675 | MG | QOW | ||||||
| 122249966 | 12224996 | 6 | SS | 5-FLUOROURACIL | FLUOROURACIL | 1 | Intravenous bolus | U | 99 | 0 | 675 | MG | QOW | ||||||
| 122249966 | 12224996 | 7 | SS | 5-FLUOROURACIL | FLUOROURACIL | 1 | Intravenous bolus | U | 99 | 0 | 675 | MG | QOW | ||||||
| 122249966 | 12224996 | 8 | SS | 5-FLUOROURACIL | FLUOROURACIL | 1 | Intravenous bolus | U | 99 | 0 | 650 | MG | QOW | ||||||
| 122249966 | 12224996 | 9 | SS | 5-FLUOROURACIL | FLUOROURACIL | 1 | Intravenous bolus | U | 99 | 0 | 575 | MG | QOW | ||||||
| 122249966 | 12224996 | 10 | SS | 5-FLUOROURACIL | FLUOROURACIL | 1 | Intravenous drip | U | 99 | 0 | 4000 | MG | QOW | ||||||
| 122249966 | 12224996 | 11 | SS | 5-FLUOROURACIL | FLUOROURACIL | 1 | Intravenous drip | U | 99 | 0 | 3900 | MG | QOW | ||||||
| 122249966 | 12224996 | 12 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | Intravenous (not otherwise specified) | 14/OCT/2015, 28/OCT/2015, 18/NOV/2015, 02/DEC/2015, 21/DEC/2015, HE RECEIVED SUBSEQUENT DOSES OF OXA | U | 99 | 0 | 140 | MG | QOW | |||||
| 122249966 | 12224996 | 13 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | Intravenous (not otherwise specified) | U | 99 | 0 | 120 | MG | QOW | ||||||
| 122249966 | 12224996 | 14 | C | FOLINIC ACID | LEUCOVORIN | 1 | Intravenous (not otherwise specified) | 400 MG ONLY ON 23-SEP-2015 | 0 | 670 | MG | QOW | |||||||
| 122249966 | 12224996 | 15 | C | FOLINIC ACID | LEUCOVORIN | 1 | Intravenous (not otherwise specified) | 400-670 MG | 0 | QOW | |||||||||
| 122249966 | 12224996 | 16 | C | PANITUMUMAB | PANITUMUMAB | 1 | Intravenous (not otherwise specified) | ONCE | 0 | 540 | MG | ||||||||
| 122249966 | 12224996 | 17 | C | DERMATOP | PREDNICARBATE | 1 | Unknown | 0 | 99 | ML | |||||||||
| 122249966 | 12224996 | 18 | C | LOPERAMID | LOPERAMIDE | 1 | Oral | 0 | 99 | MG | |||||||||
| 122249966 | 12224996 | 19 | C | NADIXA | 2 | Unknown | 0 | 99 | ML | ||||||||||
| 122249966 | 12224996 | 20 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 0 | 100 | MG | QD | ||||||||
| 122249966 | 12224996 | 21 | C | MCP | METOCLOPRAMIDE HYDROCHLORIDE | 1 | Oral | 0 | 10 | MG | |||||||||
| 122249966 | 12224996 | 22 | C | PANTOZOL | PANTOPRAZOLE SODIUM | 1 | Oral | 0 | 40 | MG | |||||||||
| 122249966 | 12224996 | 23 | C | TAVOR (LORAZEPAM) | LORAZEPAM | 1 | Oral | 0 | 1 | MG | |||||||||
| 122249966 | 12224996 | 24 | C | ATOSIL (GERMANY) | 2 | Intravenous (not otherwise specified) | 0 | 25 | MG | ||||||||||
| 122249966 | 12224996 | 25 | C | CIPROBAY | CIPROFLOXACIN | 1 | Oral | 0 | 500 | MG | BID | ||||||||
| 122249966 | 12224996 | 26 | C | CLEXANE | ENOXAPARIN SODIUM | 1 | Subcutaneous | 0 | .2 | ML | QD | ||||||||
| 122249966 | 12224996 | 27 | C | CLONIDIN | CLONIDINE | 1 | Intravenous (not otherwise specified) | 0 | .15 | MG | |||||||||
| 122249966 | 12224996 | 28 | C | METOPROLOL. | METOPROLOL | 1 | Oral | 0 | 50 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122249966 | 12224996 | 1 | Colorectal cancer |
| 122249966 | 12224996 | 3 | Colorectal cancer |
| 122249966 | 12224996 | 12 | Colorectal cancer |
| 122249966 | 12224996 | 14 | Colorectal cancer |
| 122249966 | 12224996 | 16 | Colorectal cancer |
| 122249966 | 12224996 | 17 | Erythema |
| 122249966 | 12224996 | 18 | Diarrhoea |
| 122249966 | 12224996 | 19 | Erythema |
| 122249966 | 12224996 | 20 | Cerebrovascular disorder |
| 122249966 | 12224996 | 21 | Nausea |
| 122249966 | 12224996 | 23 | Surgery |
| 122249966 | 12224996 | 24 | Hypertension |
| 122249966 | 12224996 | 25 | Urinary tract infection |
| 122249966 | 12224996 | 26 | Thrombosis |
| 122249966 | 12224996 | 27 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122249966 | 12224996 | OT |
| 122249966 | 12224996 | HO |
| 122249966 | 12224996 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122249966 | 12224996 | Abscess | |
| 122249966 | 12224996 | Anaemia | |
| 122249966 | 12224996 | Anorectal infection | |
| 122249966 | 12224996 | Ascites | |
| 122249966 | 12224996 | Delirium | |
| 122249966 | 12224996 | Faecaloma | |
| 122249966 | 12224996 | Haemoglobin decreased | |
| 122249966 | 12224996 | Haemorrhage | |
| 122249966 | 12224996 | Hypertension | |
| 122249966 | 12224996 | Proctalgia | |
| 122249966 | 12224996 | Pyrexia | |
| 122249966 | 12224996 | Subileus | |
| 122249966 | 12224996 | Wound haemorrhage | |
| 122249966 | 12224996 | Wound infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122249966 | 12224996 | 1 | 20151118 | 20151118 | 0 | |
| 122249966 | 12224996 | 2 | 20160111 | 20160111 | 0 | |
| 122249966 | 12224996 | 3 | 20150923 | 20150923 | 0 | |
| 122249966 | 12224996 | 4 | 20160111 | 20160113 | 0 | |
| 122249966 | 12224996 | 5 | 20151014 | 20151118 | 0 | |
| 122249966 | 12224996 | 6 | 20151028 | 20151028 | 0 | |
| 122249966 | 12224996 | 7 | 20151118 | 20151118 | 0 | |
| 122249966 | 12224996 | 8 | 20151202 | 20151221 | 0 | |
| 122249966 | 12224996 | 9 | 20160111 | 20160111 | 0 | |
| 122249966 | 12224996 | 10 | 20150923 | 20151120 | 0 | |
| 122249966 | 12224996 | 11 | 20151202 | 20151223 | 0 | |
| 122249966 | 12224996 | 12 | 20150923 | 0 | ||
| 122249966 | 12224996 | 13 | 20160111 | 20160111 | 0 | |
| 122249966 | 12224996 | 14 | 20151014 | 20151018 | 0 | |
| 122249966 | 12224996 | 15 | 20150923 | 20160111 | 0 | |
| 122249966 | 12224996 | 16 | 20151028 | 20151028 | 0 | |
| 122249966 | 12224996 | 17 | 20151103 | 20151221 | 0 | |
| 122249966 | 12224996 | 18 | 20160111 | 0 | ||
| 122249966 | 12224996 | 19 | 20151103 | 20151221 | 0 | |
| 122249966 | 12224996 | 20 | 2009 | 20160313 | 0 | |
| 122249966 | 12224996 | 21 | 20150916 | 201601 | 0 | |
| 122249966 | 12224996 | 22 | 20150923 | 20160316 | 0 | |
| 122249966 | 12224996 | 23 | 20160228 | 20160316 | 0 | |
| 122249966 | 12224996 | 24 | 20160302 | 20160320 | 0 | |
| 122249966 | 12224996 | 25 | 20160209 | 20160221 | 0 | |
| 122249966 | 12224996 | 26 | 20160203 | 20160213 | 0 | |
| 122249966 | 12224996 | 27 | 20160229 | 0 | ||
| 122249966 | 12224996 | 28 | 20160129 | 20160203 | 0 |